NovaBridge Biosciences (NBP) Cash from Operations (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Cash from Operations of 14596000.0 for Q4 2025, down 33.31% year-on-year from 21886004.38 in Q4 2024, and down 893.69% on a QoQ basis from 1839000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Cash from Operations (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Cash from Operations for 4 consecutive years, with 14596000.0 the latest figure, recorded in Q4 2025.
- Quarterly Cash from Operations fell 33.31% year-over-year to 14596000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 15284000.0 (down 112.72% YoY) and the FY2025 annual result came in at 20597000.0, up 60.89% from the prior year.
- Cash from Operations slipped to 14596000.0 in Q4 2025 per NBP's latest filing, from 1839000.0 in the prior quarter.
- Over the last five years, Cash from Operations for NBP reached as high as 8422000.0 in Q3 2024 and fell as low as 14596000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -14.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.60 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Dec 31, 2024 | -10.95 Mn |
| Dec 31, 2024 | -10.95 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Dec 31, 2020 | 153.34 Mn |
| Dec 31, 2020 | 153.34 Mn |
| Dec 31, 2019 | -30.64 Mn |
| Dec 31, 2019 | -30.64 Mn |